Spots Global Cancer Trial Database for 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus

Official Title: A Prospective 10 Year Observational Registry of Pediatric Subjects (Age Greater Than or Equal to Two Years to Age Less Than or Equal to 17 Years) With Atopic Dermatitis Who Have Used Elidel Cream 1% (Pimecrolimus)

Study ID: NCT00568997

Conditions

Atopic Dermatitis

Interventions

Pimecrolimus

Study Description

Brief Summary: This study will examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.

Detailed Description: Registry study to examine the risk of systemic malignancies in pediatric patients with atopic dermatitis exposed to Elidel 1% cream.